Standard Chemical Revenue vs. Price To Earning
| 1720 Stock | TWD 64.40 0.30 0.46% |
For Standard Chemical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Standard Chemical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Standard Chemical Pharmaceutical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Standard Chemical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Standard Chemical Pharmaceutical over time as well as its relative position and ranking within its peers.
Standard |
Standard Chemical Price To Earning vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Standard Chemical's current stock value. Our valuation model uses many indicators to compare Standard Chemical value to that of its competitors to determine the firm's financial worth. Standard Chemical Pharmaceutical is the top company in revenue category among its peers. It also is number one stock in price to earning category among its peers . The ratio of Revenue to Price To Earning for Standard Chemical Pharmaceutical is about 292,880,534 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Standard Chemical's earnings, one of the primary drivers of an investment's value.Standard Revenue vs. Competition
Standard Chemical Pharmaceutical is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 859.05 Billion. Standard Chemical maintains roughly 4.6 Billion in revenue contributing less than 1% to equities under Health Care industry.
Standard Price To Earning vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Standard Chemical |
| = | 4.6 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Standard Chemical |
| = | 15.72 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Standard Price To Earning Comparison
Standard Chemical is currently under evaluation in price to earning category among its peers.
Standard Chemical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Standard Chemical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Standard Chemical will eventually generate negative long term returns. The profitability progress is the general direction of Standard Chemical's change in net profit over the period of time. It can combine multiple indicators of Standard Chemical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Standard Chem Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products in Taiwan and internationally. The company was founded in 1967 and is headquartered in Tainan City, Taiwan. STANDARD CHEM operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
Standard Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Standard Chemical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Standard Chemical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Standard Chemical's important profitability drivers and their relationship over time.
Use Standard Chemical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Standard Chemical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Chemical will appreciate offsetting losses from the drop in the long position's value.Standard Chemical Pair Trading
Standard Chemical Pharmaceutical Pair Trading Analysis
The ability to find closely correlated positions to Standard Chemical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Standard Chemical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Standard Chemical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Standard Chemical Pharmaceutical to buy it.
The correlation of Standard Chemical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Standard Chemical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Standard Chemical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Standard Chemical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Standard Chemical position
In addition to having Standard Chemical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Management Thematic Idea Now
Health Management
Major hospitals and healthcare providers. The Health Management theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Management Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Standard Stock Analysis
When running Standard Chemical's price analysis, check to measure Standard Chemical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Chemical is operating at the current time. Most of Standard Chemical's value examination focuses on studying past and present price action to predict the probability of Standard Chemical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Chemical's price. Additionally, you may evaluate how the addition of Standard Chemical to your portfolios can decrease your overall portfolio volatility.